Kenichi Hirano

Title: Kenichi Hirano: Innovator in Enzymatic Determination

Introduction

Kenichi Hirano is a notable inventor based in Iwakura, Japan. He has made significant contributions to the field of enzymatic analysis, particularly in the quantitative determination of physiological components. With a total of 2 patents, his work has implications for medical diagnostics and biochemical research.

Latest Patents

Hirano's latest patents focus on innovative methods for the quantitative determination of bilirubin in biological fluids. The first patent describes a novel enzyme of bilirubin oxidase and a conventional enzyme of laccase that oxidize bilirubin to biliverdin without producing hydrogen peroxide. This method allows for the accurate measurement of conjugated bilirubin in biological fluids. The second patent also involves a bilirubin oxidase produced by microorganisms of the genus Myrothecium or Coprinus. This method, in the presence of specific additive compounds, enables the oxidation of both conjugated and unconjugated bilirubin, preventing interference in the determination of other physiological components.

Career Highlights

Kenichi Hirano is currently associated with Amano Pharmaceutical Co., Ltd., where he continues to advance his research in enzymatic applications. His work has garnered attention for its potential to improve diagnostic accuracy in clinical settings.

Collaborations

Hirano has collaborated with notable colleagues, including Akira Kosaka and Sawao Murao, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kenichi Hirano's contributions to enzymatic determination highlight his role as a key innovator in the field. His patents reflect a commitment to enhancing medical diagnostics through innovative methodologies.